Cord Tissue-Derived Mesenchymal Stromal Cells therapy(Charles Cox)

N/A

Report date: 2023/12/06 20:07:23

Base Information

Drug NameCord Tissue-Derived Mesenchymal Stromal Cells therapy(Charles Cox)
Drug Alias NameAllogenic Human Cord Tissue Derived Mesenchymal Stromal Cells (hCTMSCs)(Charles Cox)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsPost-Acute COVID-19 Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCbr Systems Inc
China Registration ClassN/A

Develop Information

Active CompaniesCbr Systems Inc
Inactive CompaniesN/A
Active IndicationsPost-Acute COVID-19 Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A